MedTrace Logo

Long-Term Evaluation of the Performance and Safety of the IntraSPINE® Interlaminar Implant in the Treatment of Lumbar Degenerative Disc Disease

NCT07790328 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-08-27

No results posted yet for this study

Summary

This is an observational study designed as an extension of a prospective study conducted between 2012 and 2017. Patients who were originally enrolled in the initial study are being recontacted for follow-up assessment, including evaluation of clinical and radiological (MRI) criteria. Approximately 50 patients have been included to date and their long terms results (at least 9 years) will be assessed.

Conditions

  • Lower Back Pain of Disc Origin
  • Joint Facet Syndrome
  • Lumbar Canal Stenosis
  • Spinal Disease

Interventions

DRUG

IntraSPINE

Intraspine is an interlaminar device not interspinous.

Sponsors & Collaborators

  • Cousin Biotech

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2026-06-01
Completion
2031-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07790328 on ClinicalTrials.gov